BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19715529)

  • 1. Late fulminant posterior reversible encephalopathy syndrome after liver transplant.
    Heidenhain C; Puhl G; Neuhaus P
    Exp Clin Transplant; 2009 Sep; 7(3):180-3. PubMed ID: 19715529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of calcineurin inhibitor-associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients.
    Akutsu N; Iwashita C; Maruyama M; Ootsuki K; Ito T; Saigo K; Kenmochi T
    Transplant Proc; 2008 Sep; 40(7):2416-8. PubMed ID: 18790253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation.
    Hayes D; Adler B; Turner TL; Mansour HM
    Pediatr Neurol; 2014 Mar; 50(3):272-5. PubMed ID: 24405697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overdose of Tacrolimus as the Trigger Causing Progression of Posterior Reversible Encephalopathy Syndrome and Subsequent Hepatic Infarction After Liver Transplant: A Case Report.
    Tseng WC; Lai HC; Yeh CC; Fan HL; Wu ZF
    Exp Clin Transplant; 2020 Feb; 18(1):128-132. PubMed ID: 30602365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reversible posterior leukoencephalopathy induced by tacrolimus in a renal transplant patient].
    Izquierdo Pajuelo MJ; Jiménez Delgado JD; Rangel Mayoral JF; Liso Rubio FJ
    Farm Hosp; 2009; 33(3):177-8. PubMed ID: 19712604
    [No Abstract]   [Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome in the Intensive Care Unit after liver transplant: a comparison of our experience with the existing literature.
    Lunardi N; Saraceni E; Boccagni P; Segato M; Bortolato A; Manara R; Rossi S; Ori C
    Minerva Anestesiol; 2012 Jul; 78(7):847-50. PubMed ID: 21701444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior reversible encephalopathy syndrome after liver transplantation in children: a rare complication related to calcineurin inhibitor effects.
    Santos MM; Tannuri AC; Gibelli NE; Ayoub AA; Maksoud-Filho JG; Andrade WC; Velhote MC; Silva MM; Pinho ML; Miyatani HT; Susuki L; Tannuri U
    Pediatr Transplant; 2011 Mar; 15(2):157-60. PubMed ID: 21155957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior reversible encephalopathy syndrome after kidney transplantation in pediatric recipients: Two cases.
    Giussani A; Ardissino G; Belingheri M; Dilena R; Raiteri M; Pasciucco A; Colico C; Beretta C
    Pediatr Transplant; 2016 Feb; 20(1):68-71. PubMed ID: 26607205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report.
    Ramirez R; Muskula PR; Everley MP
    Am J Case Rep; 2017 May; 18():487-490. PubMed ID: 28465499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior reversible encephalopathy syndrome (PRES) as a complication of immunosuppressive therapy in renal transplantation in children.
    Hodzic E; Brcic M; Atic M; Halilcevic A; Jasarevic A; Aleckovic-Halilovic M; Trojak D; Atic N; Zulic S; Mehmedovic Z; Iveljic I
    Med Arh; 2014; 68(3):218-20. PubMed ID: 25195358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible posterior leukoencephalopathy syndrome (RPLS) in a heart transplant recipient treated by substitution of cyclosporine A with tacrolimus.
    Oda N; Kato TS; Hanatani A; Niwaya K; Nakatani T; Ishibashi-Ueda H; Kitamura S; Hashimura K; Kitakaze M; Komamura K
    Intern Med; 2010; 49(11):1013-6. PubMed ID: 20519818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review.
    Song T; Rao Z; Tan Q; Qiu Y; Liu J; Huang Z; Wang X; Lin T
    Medicine (Baltimore); 2016 Apr; 95(14):e3173. PubMed ID: 27057842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation.
    Barbas AS; Rege AS; Castleberry AW; Gommer J; Ellis MJ; Brennan TV; Collins BH; Martin AE; Ravindra KV; Vikraman DS; Sudan DL
    Am J Transplant; 2013 Mar; 13(3):808-10. PubMed ID: 23331705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated leptomeningeal enhancement in tacrolimus-associated posterior reversible encephalopathy syndrome.
    Fitzgerald RT; Osorio J; Panigrahy A; Mazariegos GV; Zuccoli G
    Pediatr Neurol; 2013 Jan; 48(1):76-8. PubMed ID: 23290027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior reversible encephalopathy syndrome and hemorrhage associated with tacrolimus in a pediatric heart transplantation recipient.
    Loar RW; Patterson MC; O'Leary PW; Driscoll DJ; Johnson JN
    Pediatr Transplant; 2013 Mar; 17(2):E67-70. PubMed ID: 23331314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.
    Karie-Guigues S; Janus N; Saliba F; Dumortier J; Duvoux C; Calmus Y; Lorho R; Deray G; Launay-Vacher V; Pageaux GP
    Liver Transpl; 2009 Sep; 15(9):1083-91. PubMed ID: 19718632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant patient: case report.
    Riveiro-Barciela M; Campos-Varela I; Tovar JL; Vargas V; Simón-Talero M; Ventura-Cots M; Crespo M; Bilbao I; Castells L
    Transplant Proc; 2011 Dec; 43(10):4016-8. PubMed ID: 22172892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior Reversible Encephalopathy Syndrome (PRES) as a Complication of Immunosuppressive Therapy in Renal Transplantation in Children.
    Hodzic E; Brcic M; Atic M; Halilcevic A; Jasarevic A; Aleckovic-Halilovic M; Trojak D; Atic N; Zulic S; Mehmedovic Z; Iveljic I
    Med Arch; 2014 Jun; 68(3):218-20. PubMed ID: 25568539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus associated to posterior reversible atypical encephalopathy syndrome and brain haemorrhage in renal transplant recipient.
    Cadavid-Aljure D; Caicedo-Paredes A; Meza JC; Granados-Sánchez AM; Posada-Chávez JG; Mesa-Ramírez L; Schweineberg-López J
    Nefrologia; 2012; 32(6):861-3. PubMed ID: 23169384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.